Novolin N is human NPH insulin — an intermediate-acting formulation that typically starts working in 1 to 3 hours, peaks at 4 to 12 hours, and lasts roughly 12 to 18 hours. It is often used once or twice daily as basal coverage and is one of the most affordable insulins because it is available over the counter in most U.S. states.
What NPH Insulin Is
NPH stands for Neutral Protamine Hagedorn, named after Danish scientist Hans Christian Hagedorn, who developed the formulation in the 1930s by adding protamine to insulin to slow its absorption. The result is a suspension rather than a solution — NPH looks cloudy because it contains crystalline particles that dissolve gradually under the skin.
According to the FDA prescribing information, Novolin N is regular human insulin modified with protamine-zinc complexes. It is a recombinant DNA product — biologically identical to human insulin — not an analog like glargine (Lantus) or detemir (Levemir).
Onset, Peak, and Duration
| Parameter | Novolin N (NPH) |
|---|---|
| Onset | 1 to 3 hours |
| Peak | 4 to 12 hours |
| Duration | 12 to 18 hours |
| Typical dosing | Once or twice daily |
| Appearance | Cloudy suspension |
The pronounced peak is the key clinical difference from modern basal analogs. In practice this means mid-day or middle-of-the-night hypoglycemia risk is higher than with glargine or degludec, which have relatively flat profiles. Careful meal and snack timing around the peak can reduce — but not eliminate — this risk.
When Novolin N Is Used
Novolin N has several common roles in diabetes care:
- Basal coverage in type 2 diabetes, often given at bedtime to control morning fasting glucose.
- Twice-daily regimens, typically split between breakfast and dinner (or bedtime) for fuller coverage.
- Conventional regimens in type 1 diabetes, though basal-bolus with analog insulins is now standard.
- Low-cost alternative when analog insulin is unaffordable — a very real concern for uninsured patients.
- Pre-mixed products (Novolin 70/30, Humulin 70/30) combine NPH with regular insulin.
For people with prediabetes, insulin is not a first-line therapy. It is reserved for clinical diabetes with meaningfully elevated A1C or symptomatic hyperglycemia.
How to Use Novolin N Correctly
Resuspending the Insulin
Because NPH is a suspension, the crystals settle out during storage. Before every dose:
- Gently roll the vial or pen between your palms 10 to 20 times. Do not shake — shaking creates bubbles and damages the protein.
- Invert the vial or pen gently a few times.
- Confirm the insulin looks uniformly cloudy. Clumps, frost, or clear liquid mean the pen has gone bad and should be discarded.
Injection Technique
Inject subcutaneously into the abdomen, thigh, or upper arm. Rotate within an area to avoid lipohypertrophy. Use a new needle each time, and hold the needle in place for a few seconds after pressing the plunger.
Timing
Most regimens time Novolin N so the peak coincides with elevated glucose periods — for example, bedtime dosing peaks in the early morning to counteract the dawn phenomenon. A clinician sets and adjusts the schedule based on your glucose patterns.
Dosing Principles
Dosing is individualized. Common starting points in type 2 diabetes include 10 units at bedtime or 0.1 to 0.2 units/kg/day, adjusted every few days based on fasting glucose. Fasting glucose targets are usually 80 to 130 mg/dL for most non-pregnant adults, per the ADA Standards of Care. Your clinician may use fasting values to titrate upward by 1 to 2 units at a time.
Side Effects and Safety
The most important adverse effect is hypoglycemia, especially during the peak window. Warning signs include shakiness, sweating, rapid heartbeat, irritability, and confusion. Because NPH peaks 4 to 12 hours after injection, nocturnal hypoglycemia is a particular concern with bedtime dosing.
Other possible issues include:
- Weight gain, common with any insulin therapy.
- Injection-site reactions, lipohypertrophy.
- Rare allergic reactions.
- Hypokalemia (low potassium), clinically relevant only in specific situations.
Storage
| Status | Storage | Duration |
|---|---|---|
| Unopened vial | Refrigerator, 36 to 46 F | Until expiration |
| Opened vial | Room temperature or refrigerator | 42 days (Novolin N vial) |
| Opened FlexPen | Room temperature, not refrigerator | 14 days |
| Frozen or overheated | Discard | Do not use |
Always check the specific Instructions for Use for your pen or vial — storage times can vary slightly by product and manufacturer updates.
Novolin N vs. Modern Basal Analogs
| Feature | Novolin N (NPH) | Glargine (Lantus) | Degludec (Tresiba) |
|---|---|---|---|
| Duration | 12 to 18 hours | ~24 hours | Greater than 42 hours |
| Peak | Pronounced (4 to 12 h) | Relatively flat | Flat |
| Hypoglycemia risk | Higher | Lower | Lowest among basals |
| Typical cost (uninsured) | Low (OTC) | Moderate | High |
| Appearance | Cloudy | Clear | Clear |
Analog insulins generally cause fewer hypoglycemic events and allow simpler once-daily dosing. Whether their added cost is justified depends on insurance coverage, your A1C pattern, and your lifestyle. Discuss these trade-offs with your clinician — do not switch insulins on your own.
Who Might Still Prefer Novolin N
- People without insurance paying cash at a pharmacy.
- Patients whose regimens have been stable for years with good control and minimal hypoglycemia.
- Short-term or emergency coverage when analog insulin is unavailable.
If cost is a barrier, ask your pharmacist about treatment assistance programs, manufacturer savings cards, and state insulin price caps — many patients qualify for sharply reduced pricing on analog insulins.
The Bottom Line
Novolin N is a reliable, affordable intermediate-acting insulin with a long track record. Its peak can be managed but not eliminated, so users must understand hypoglycemia timing and routine resuspension. Modern analog basal insulins offer flatter action and fewer lows but cost more. The best choice is the one that matches your glucose targets, lifestyle, and budget — decided with your care team, not in isolation.
